New Medicare Local Coverage Determinations Published for the HeartFlow Analysis
Patients with stable chest pain in 38 states now have formal Medicare coverage for the HeartFlow Analysis REDWOOD CITY, Calif. – April 6, 2021 — HeartFlow, Inc., a leader in revolutionizing precision heartcare, announced today that three more Medicare Administrative Contractors (MACs) have published final Local Coverage Determinations (LCDs) providing coverage for the HeartFlow FFRCT Analysis. With […]
New 10-Year Data Demonstrate Superiority of the HeartFlow Analysis in Predicting Long-Term Outcomes in Patients with Coronary Artery Disease
New 10-Year Data Demonstrate Superiority of the HeartFlow Analysis in Predicting Long-Term Outcomes in Patients with Coronary Artery Disease
NHS England and NHS Improvement mandate adoption of AI-powered HeartFlow Analysis to fight coronary heart disease
NHS England and NHS Improvement mandate adoption of AI-powered HeartFlow Analysis to fight coronary heart disease
New JAMA Network Open Publication Demonstrates the Coronary CT-HeartFlow Analysis Pathway is ‘Dominant’ Compared to Stress Testing in Cost-Effectiveness Analysis
New JAMA Network Open Publication Demonstrates the Coronary CT-HeartFlow Analysis Pathway is ‘Dominant’ Compared to Stress Testing in Cost-Effectiveness Analysis
HeartFlow Appoints Cybersecurity Expert Julie Cullivan to its Board of Directors
REDWOOD CITY, Calif. – November 19, 2020 — HeartFlow, Inc., a leader in revolutionizing precision heartcare, has named Julie Cullivan, Chief Information Officer of Forescout Technologies, Inc., the leader in Enterprise of Things security, to its Board of Directors, effective November 19, 2020. “Julie’s long-time leadership in the technology and cybersecurity industry will provide substantial strategic […]
HeartFlow Highlights Two Presentations at the 2020 American Heart Association Virtual Meeting
HeartFlow Highlights Two Presentations at the 2020 American Heart Association Virtual Meeting
HeartFlow Applauds Healthcare Stakeholders’ Push for Change in How Coronary Artery Disease is First Diagnosed
HeartFlow Applauds Healthcare Stakeholders’ Push for Change in How Coronary Artery Disease is First Diagnosed
New Data Highlight a Significant Increase in Cardiovascular Treatment Efficiency when the HeartFlow Analysis is Incorporated into the Diagnostic Pathway
New Data Highlight a Significant Increase in Cardiovascular Treatment Efficiency when the HeartFlow Analysis is Incorporated into the Diagnostic Pathway
NHS England to Extend Reimbursement for the HeartFlow Analysis through Innovation and Technology Payment (ITP) Program
ITP Program extended in recognition of the positive impact of the HeartFlow Analysis on patient management, streamlining treatment strategies and reducing waiting lists REDWOOD CITY, Calif. – June 5, 2019 – HeartFlow, Inc. today announced that NHS England has extended HeartFlow’s participation in the Innovation and Technology Payment (ITP) program for an additional year. As part of the extension, NHS […]
Use of HeartFlow Planner Leads to Change in Treatment Strategy in Nearly Half of Patients with Coronary Heart Disease
Use of HeartFlow Planner Leads to Change in Treatment Strategy in Nearly Half of Patients with Coronary Heart Disease